MorphoSys AG (MOR)
17.42
+0.06
(+0.37%)
USD |
NASDAQ |
Apr 30, 16:00
17.42
0.00 (0.00%)
After-Hours: 20:00
MorphoSys Market Cap: 2.629B for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 2.619B |
| April 26, 2024 | 2.722B |
| April 25, 2024 | 2.735B |
| April 24, 2024 | 2.723B |
| April 23, 2024 | 2.722B |
| April 22, 2024 | 2.710B |
| April 19, 2024 | 2.713B |
| April 18, 2024 | 2.723B |
| April 17, 2024 | 2.713B |
| April 16, 2024 | 2.700B |
| April 15, 2024 | 2.710B |
| April 12, 2024 | 2.716B |
| April 11, 2024 | 2.715B |
| April 10, 2024 | 2.710B |
| April 09, 2024 | 2.731B |
| April 08, 2024 | 2.730B |
| April 05, 2024 | 2.721B |
| April 04, 2024 | 2.719B |
| April 03, 2024 | 2.722B |
| April 02, 2024 | 2.716B |
| April 01, 2024 | 2.724B |
| March 28, 2024 | 2.728B |
| March 27, 2024 | 2.728B |
| March 26, 2024 | 2.734B |
| March 25, 2024 | 2.730B |
| Date | Value |
|---|---|
| March 22, 2024 | 2.734B |
| March 21, 2024 | 2.712B |
| March 20, 2024 | 2.712B |
| March 19, 2024 | 2.721B |
| March 18, 2024 | 2.722B |
| March 15, 2024 | 2.683B |
| March 14, 2024 | 2.698B |
| March 13, 2024 | 2.713B |
| March 12, 2024 | 2.733B |
| March 11, 2024 | 2.691B |
| March 08, 2024 | 2.694B |
| March 07, 2024 | 2.685B |
| March 06, 2024 | 2.677B |
| March 05, 2024 | 2.661B |
| March 04, 2024 | 2.668B |
| March 01, 2024 | 2.662B |
| February 29, 2024 | 2.647B |
| February 28, 2024 | 2.644B |
| February 27, 2024 | 2.658B |
| February 26, 2024 | 2.661B |
| February 23, 2024 | 2.650B |
| February 22, 2024 | 2.664B |
| February 21, 2024 | 2.655B |
| February 20, 2024 | 2.646B |
| February 16, 2024 | 2.629B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
438.62M
Minimum
Dec 27 2022
4.742B
Maximum
Jan 09 2020
2.221B
Average
1.975B
Median
Aug 27 2021
Market Cap Benchmarks
| Incyte Corp | 11.70B |
| Novartis AG | 198.19B |
| Immatics NV | 1.024B |
| Affimed NV | 80.86M |
| InflaRx NV | 81.85M |
Market Cap Related Metrics
| PS Ratio | 9.274 |
| PEG Ratio | -0.6623 |
| Price to Book Value | 48.49 |
| Price | 17.42 |
| Earnings Yield | -8.63% |
| PEGY Ratio | -0.6623 |